CN112675212A - Scutellaria baicalensis ointment and preparation method and application thereof - Google Patents

Scutellaria baicalensis ointment and preparation method and application thereof Download PDF

Info

Publication number
CN112675212A
CN112675212A CN202110049077.8A CN202110049077A CN112675212A CN 112675212 A CN112675212 A CN 112675212A CN 202110049077 A CN202110049077 A CN 202110049077A CN 112675212 A CN112675212 A CN 112675212A
Authority
CN
China
Prior art keywords
parts
ointment
mixture
scutellaria
ethylparaben
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110049077.8A
Other languages
Chinese (zh)
Inventor
赵秋华
马卓飞
黄元河
周新花
张忠伟
凌博
梁威
夏小燕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Youjiang Medical University for Nationalities
Original Assignee
Youjiang Medical University for Nationalities
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Youjiang Medical University for Nationalities filed Critical Youjiang Medical University for Nationalities
Priority to CN202110049077.8A priority Critical patent/CN112675212A/en
Publication of CN112675212A publication Critical patent/CN112675212A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The invention discloses a scutellaria ointment which is mainly prepared from the following raw materials: scutellaria root, borneol, stearic acid, glyceryl monostearate, liquid paraffin, glycerine, triethanolamine, ethylparaben and distilled water, and its preparation method includes the following steps: (1) decocting Scutellariae radix tablet in water twice, mixing decoctions, heating and concentrating with direct fire, and freeze drying to obtain Scutellariae radix extract powder; (2) putting stearic acid, glyceryl monostearate, castor oil and ethylparaben in a beaker, heating in water bath for complete dissolution to obtain a mixture A; (3) putting the glycerol, the scutellaria baicalensis extract powder and the distilled water into another beaker, heating to 50-60 ℃, adding triethanolamine while stirring to completely dissolve the scutellaria baicalensis extract powder to obtain a mixture B; and (4) adding borneol into the mixture A to obtain a mixture C, and then gradually adding the mixture C into the mixture B while stirring uniformly to room temperature to obtain the borneol-. The radix scutellariae ointment has the advantages of high efficiency and no side effect.

Description

Scutellaria baicalensis ointment and preparation method and application thereof
Technical Field
The invention relates to the technical field of traditional Chinese medicine preparation, and in particular relates to a scutellaria baicalensis ointment and a preparation method thereof.
Background
The Scutellariae radix is dried root of Scutellaria baicalensis Georgi of Labiatae, has been used for thousands of years in China, and is safe and harmless. Baikal skullcap root is first recorded in the Chinese herbal medicine of Shennong Ben Cao Jing, and is recorded in the form of Baikal skullcap root, bitter and flat in taste, all kinds of fever, jaundice, intestine , diarrhea, water retention, bleeding obstruction, malignant boil, deep-rooted carbuncle and fire ulcer. The scutellaria has the functions of clearing away heat, purging fire, detoxicating, arresting bleeding, preventing abortion, etc. and has the functions of resisting oxidation, eliminating free radical, resisting inflammation, resisting tumor, preventing calcium channel, inhibiting aldose reductase, resisting virus, resisting allergy, etc. and protecting immunity, cardiac and cerebral blood vessel, digestive system, nerve system, etc.
The ointment prepared from scutellaria baicalensis is already available on the market for treating diseases, but the existing baicalein ointment has single component and long drug effect release time, and the scutellaria baicalensis mainly contains baicalin, baicalein and other components which have pharmacological effects of resisting bacteria, resisting tumors, resisting inflammation, resisting allergy, resisting oxidation and the like. After the extraction, the comprehensive components contained in the scutellaria baicalensis extract powder obtained by freeze drying have the effect which is more in line with the characteristics of traditional Chinese medicine pharmacy based on the traditional Chinese medicine theory.
Disclosure of Invention
The invention aims to solve the problems in the prior art and provides the baicalein ointment which has the advantages of reasonable formula, obvious curative effect, simple preparation method, no side effect, no drug residue and effective baicalein.
The raw materials of the invention are all from Chinese herbal medicines, and the scutellaria baicalensis ointment is scientifically prepared, and the medicine has the functions of antibiosis, tumor resistance, inflammation resistance, allergy resistance, oxidation resistance and the like.
In order to realize the purpose of the invention, the adopted technical scheme is as follows:
the scutellaria ointment is characterized by being mainly prepared from the following raw materials: scutellaria root, borneol, stearic acid, glyceryl monostearate, liquid paraffin, glycerine, triethanolamine, ethylparaben and distilled water.
Preferably, the ointment mainly comprises the following raw materials in parts by weight: 50-100 parts of scutellaria baicalensis, 0.5-1 part of borneol, 30-60 parts of stearic acid, 10-20 parts of glyceryl monostearate, 50-100 parts of liquid paraffin, 20-60 parts of glycerol, 0.5-1 part of triethanolamine, 0.25-0.5 part of ethylparaben and 100-200 parts of distilled water.
Preferably, the ointment mainly comprises the following raw materials in parts by weight: 50 parts of scutellaria baicalensis, 0.5 part of borneol, 30 parts of stearic acid, 10 parts of glycerin monostearate, 50 parts of liquid paraffin, 20 parts of glycerol, 0.5 part of triethanolamine, 0.25 part of ethylparaben and 100 parts of distilled water.
Preferably, the ointment mainly comprises the following raw materials in parts by weight: 100 parts of scutellaria baicalensis, 1 part of borneol, 60 parts of stearic acid, 20 parts of glycerin monostearate, 100 parts of liquid paraffin, 60 parts of glycerin, 1 part of triethanolamine, 0.5 part of ethylparaben and 200 parts of distilled water.
The invention also provides a preparation method of the scutellaria baicalensis ointment, which comprises the following steps:
(1) decocting Scutellariae radix slice with water twice, mixing decoctions, heating and concentrating with direct fire, and freeze drying to obtain Scutellariae radix extract powder;
(2) putting stearic acid, glyceryl monostearate, castor oil and ethylparaben in a beaker, heating in water bath for complete dissolution to obtain a mixture A;
(3) putting the glycerol, the scutellaria baicalensis extract powder and the distilled water into another beaker, heating to 50-60 ℃, adding triethanolamine while stirring to completely dissolve the scutellaria baicalensis extract powder to obtain a mixture B;
(4) adding Borneolum Syntheticum into mixture A to obtain mixture C, gradually adding mixture C into mixture B, stirring, and cooling to room temperature to obtain ointment.
Furthermore, the pharmaceutical composition is a preparation prepared from crude drug powder of the raw drug materials according to the weight ratio.
Further, each time of decoction is 1 h.
Further, in the step (2), heating the mixture in a water bath to 60-70 ℃.
Further, the radix scutellariae ointment is applied to antibiosis, tumor resistance, anti-inflammation, anti-allergy and antioxidation.
The invention has the advantages and beneficial effects that:
1. the radix scutellariae ointment has the advantages of safe use, high cure rate, good treatment effect and the like in the aspects of treatment of antibiosis, tumor resistance, inflammation resistance, allergy resistance, oxidation resistance and the like.
2. The clinical application result shows that the radix scutellariae ointment has quick effect and no side effect.
3. The radix scutellariae ointment has the characteristics of preparation of both principal and secondary aspects, simple preparation process, good treatment effect, no toxic or side effect, reliable curative effect, low price, convenient use, no side effect, no drug residue and difficulty in generating drug resistance, and is worthy of clinical popularization and use.
Detailed Description
The invention will now be described in further detail with reference to the following examples, which are given for the purpose of illustration only and are not intended to limit the scope of the invention. The experimental methods used in the following examples are all conventional methods unless otherwise specified, and materials, reagents and the like used in the following examples are commercially available unless otherwise specified.
The inventor has long-term research on the antibacterial effect of the traditional Chinese medicine and has deep understanding on the efficacy and compatibility rule of the traditional Chinese medicine commonly used for treating the diseases. Under the guidance of the theory of traditional Chinese medicine, the recipe is finally formulated through prescription screening and clinical experimental statistical observation. The scutellaria ointment of the invention comprises the following components:
baikal skullcap root is used as main ingredient. It is bitter and cold in taste, and has effects of clearing heat and eliminating dampness, purging pathogenic fire and removing toxic substance, stopping bleeding, preventing miscarriage, etc. It can be used for treating epidemic febrile disease, upper respiratory infection, cough due to lung heat, yellow gallbladder due to damp-heat, pneumonia, dysentery, hemoptysis, conjunctival congestion, threatened abortion, hypertension, carbuncle, furuncle, and sore. The clinical antibacterial property of scutellaria is better than that of coptis, and the scutellaria does not produce drug resistance.
Example 1
The scutellaria ointment mainly comprises the following raw materials in parts by weight: 50 parts of scutellaria baicalensis, 0.5 part of borneol, 30 parts of stearic acid, 10 parts of glycerin monostearate, 50 parts of liquid paraffin, 20 parts of glycerol, 0.5 part of triethanolamine, 0.25 part of ethylparaben and 100 parts of distilled water.
The preparation method comprises the following steps:
(1) decocting Scutellariae radix tablet in water twice, mixing decoctions, heating and concentrating with direct fire, and freeze drying to obtain Scutellariae radix extract powder;
(2) putting stearic acid, glyceryl monostearate, castor oil and ethylparaben in a beaker, heating in water bath for complete dissolution to obtain a mixture A;
(3) placing glycerin, scutellaria baicalensis extract powder and distilled water into another beaker, heating to 50-60 ℃, adding triethanolamine while stirring to completely dissolve baicalein to obtain a mixture B; and
(4) adding Borneolum Syntheticum into mixture A to obtain mixture C, gradually adding mixture C into mixture B, stirring, and cooling to room temperature to obtain ointment.
Example 2
The scutellaria ointment mainly comprises the following raw materials in parts by weight: 100 parts of scutellaria baicalensis, 1 part of borneol, 60 parts of stearic acid, 20 parts of glycerin monostearate, 100 parts of liquid paraffin, 60 parts of glycerin, 1 part of triethanolamine, 0.5 part of ethylparaben and 200 parts of distilled water.
The preparation method comprises the following steps:
(1) decocting Scutellariae radix tablet in water twice, mixing decoctions, heating and concentrating with direct fire, and freeze drying to obtain Scutellariae radix extract powder;
(2) putting stearic acid, glyceryl monostearate, castor oil and ethylparaben in a beaker, heating in water bath for complete dissolution to obtain a mixture A;
(3) putting the glycerol, the scutellaria baicalensis extract powder and the distilled water into another beaker, heating to 50-60 ℃, adding triethanolamine while stirring to completely dissolve the scutellaria baicalensis extract powder to obtain a mixture B; and
(4) adding Borneolum Syntheticum into mixture A to obtain mixture C, gradually adding mixture C into mixture B, stirring, and cooling to room temperature to obtain ointment.
Example 3
The scutellaria ointment mainly comprises the following raw materials in parts by weight: 70 parts of scutellaria baicalensis, 0.7 part of borneol, 55 parts of stearic acid, 15 parts of glycerin monostearate, 80 parts of liquid paraffin, 45 parts of glycerol, 0.7 part of triethanolamine, 0.75 part of ethylparaben and 150 parts of distilled water.
The preparation method comprises the following steps:
(1) decocting Scutellariae radix tablet in water twice, mixing decoctions, heating and concentrating with direct fire, and freeze drying to obtain Scutellariae radix extract powder;
(2) putting stearic acid, glyceryl monostearate, castor oil and ethylparaben in a beaker, heating in water bath for complete dissolution to obtain a mixture A;
(3) putting the glycerol, the scutellaria baicalensis extract powder and the distilled water into another beaker, heating to 50-60 ℃, adding triethanolamine while stirring to completely dissolve the scutellaria baicalensis extract powder to obtain a mixture B; and
(4) adding Borneolum Syntheticum into mixture A to obtain mixture C, gradually adding mixture C into mixture B, stirring, and cooling to room temperature to obtain ointment.
The efficacy of the present invention is demonstrated by the following experimental examples.
(1) Processing raw medicinal materials
1) Extracting Scutellariae radix with ethanol to obtain Scutellariae radix extract;
2) extracting with water and precipitating with ethanol to obtain Scutellariae radix extract;
3) extracting with water and precipitating with ethanol to obtain Scutellariae radix extract, and freeze drying to obtain Scutellariae radix dry extract fine powder;
4) baicalein ointment prepared in example 2 was used;
(2) preparation of agar base
Preparing a ringer's solution: 0.85g of sodium chloride, 0.03g of potassium chloride and 0.048g of calcium chloride are taken and added with water until 100ml is dissolved.
Adding 2g of agar into the ringer's solution, heating in a water bath to dissolve, cooling to 60 ℃, adding a plurality of drops of ferric trichloride test solution, uniformly mixing, immediately pouring into 8 same test tubes preheated in advance, marking the test tubes as No. 1, 2, 3, 4, 5, 6, 7 and 8 respectively, wherein the loading amount is about 2cm away from the mouth of the test tube, pouring along the tube wall when pouring, avoiding mixing bubbles, standing vertically and solidifying for later use;
(3) taking the different ointments prepared in the step (1), respectively filling the different ointments into test tubes with agar matrixes in the step (2), wherein the different ointments are filled in the same amount, namely 1-2 No. 1 is a water extraction and alcohol precipitation method to obtain a scutellaria baicalensis extract, 3-4 No. 3 is an alcohol extraction method to obtain a scutellaria baicalensis extract, 5-6 No. 5 is a baicalein ointment prepared in the example 2, 7-8 No. 7 is a water extraction and alcohol precipitation method to obtain a scutellaria baicalensis extract, freeze-drying the scutellaria baicalensis extract to obtain scutellaria baicalensis dry extract fine powder, and then placing the scutellaria baicalensis dry extract fine powder in a constant temperature box (37 ℃) for a certain time to measure the penetration distance (namely the length of. Filling the measured data into table 1;
TABLE 1
0.5h 1h 2h 4h 8h 12h 24h 48h
1 0.4cm 0.4cm 0.6cm 0.9-3cm 1.2-3.2cm 1.3-3cm 1.7-3.2cm 2.3cm-3.2cm
2 0.5cm 0.5cm 0.7cm 0.9-3.5cm 1.3-3.6cm 1.5-5.1cm 2-5.1cm 2.7cm-5.1cm
3 0.2cm 0.2cm 0.4cm 0.5cm 0.8cm 1cm 1.3cm 1.6cm
4 0.4cm 0.4cm 0.5cm 0.6cm 0.8cm 1cm 1.5cm 1.6cm
5 0cm 0.1cm 0.3cm 0.3cm 0.2cm 0.3cm 0.3cm 0.4cm
6 0cm 0cm 0.2cm 0.3cm 0.2cm 0.3cm 0.3cm 0.4cm
7 0.4cm 0.4cm 0.5cm 0.8cm 1.1cm 1.1cm 1.6cm 1.9cm
8 0.5cm 0.8cm 0.8cm 1.1cm 1.4cm 1.9cm 2.1cm 3cm
As can be seen from table 1, the radix scutellariae ointment prepared by the embodiment has the advantages of good release, good effect, no side effect, no drug residue, low price and easy acquisition, and is worthy of clinical popularization and application.
The above description is only an embodiment of the present invention, but the scope of the present invention is not limited thereto, and any changes or substitutions that are not thought of through the inventive work should be included in the scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope defined by the claims.

Claims (8)

1. The scutellaria ointment is characterized by being mainly prepared from the following raw materials: scutellaria root, borneol, stearic acid, glyceryl monostearate, liquid paraffin, glycerine, triethanolamine, ethylparaben and distilled water.
2. The scutellaria ointment of claim 1, which is prepared from the following raw materials in parts by weight: 50-100 parts of scutellaria baicalensis, 0.5-1 part of borneol, 30-60 parts of stearic acid, 10-20 parts of glyceryl monostearate, 50-100 parts of liquid paraffin, 20-60 parts of glycerol, 0.5-1 part of triethanolamine, 0.25-0.5 part of ethylparaben and 100-200 parts of distilled water.
3. The scutellaria ointment of claim 2, which is prepared from the following raw materials in parts by weight: 50 parts of scutellaria baicalensis, 0.5 part of borneol, 30 parts of stearic acid, 10 parts of glycerin monostearate, 50 parts of liquid paraffin, 20 parts of glycerol, 0.5 part of triethanolamine, 0.25 part of ethylparaben and 100 parts of distilled water.
4. The scutellaria ointment of claim 2, which is prepared from the following raw materials in parts by weight: 100 parts of scutellaria baicalensis, 1 part of borneol, 60 parts of stearic acid, 20 parts of glycerin monostearate, 100 parts of liquid paraffin, 60 parts of glycerin, 1 part of triethanolamine, 0.5 part of ethylparaben and 200 parts of distilled water.
5. The method for preparing the ointment of scutellaria baicalensis as claimed in any one of claims 1 to 4, which comprises the following steps:
(1) decocting Scutellariae radix tablet in water twice, mixing decoctions, heating and concentrating with direct fire, and freeze drying to obtain Scutellariae radix extract powder;
(2) putting stearic acid, glyceryl monostearate, castor oil and ethylparaben in a beaker, heating in water bath for complete dissolution to obtain a mixture A;
(3) placing glycerin, scutellaria baicalensis extract powder and distilled water into another beaker, heating to 50-60 ℃, adding triethanolamine while stirring to completely dissolve baicalein to obtain a mixture B; and
(4) adding Borneolum Syntheticum into mixture A to obtain mixture C, gradually adding mixture C into mixture B, stirring, and cooling to room temperature to obtain ointment.
6. The method for preparing ointment of Scutellariae radix of claim 5, wherein in step (1), decocting is carried out for 1h each time.
7. The method for preparing baicalein ointment as claimed in claim 5, wherein in the step (2), the ointment is heated to 60-70 ℃ in water bath.
8. Use of the scutellaria ointment of any one of claims 1-4 for antibacterial, anti-tumor, anti-inflammatory, anti-allergic, and anti-oxidant purposes.
CN202110049077.8A 2021-01-14 2021-01-14 Scutellaria baicalensis ointment and preparation method and application thereof Pending CN112675212A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110049077.8A CN112675212A (en) 2021-01-14 2021-01-14 Scutellaria baicalensis ointment and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110049077.8A CN112675212A (en) 2021-01-14 2021-01-14 Scutellaria baicalensis ointment and preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN112675212A true CN112675212A (en) 2021-04-20

Family

ID=75457965

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110049077.8A Pending CN112675212A (en) 2021-01-14 2021-01-14 Scutellaria baicalensis ointment and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN112675212A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116492358A (en) * 2023-04-10 2023-07-28 陕西中医药大学 Application of scutellarin monomer

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
程敏: "《中药药剂学实验指导》", 31 July 2016, 东南出版社 *
郝翠等: "正交试验法优选黄芩配方颗粒的水提工艺", 《中国民族民间医药》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116492358A (en) * 2023-04-10 2023-07-28 陕西中医药大学 Application of scutellarin monomer

Similar Documents

Publication Publication Date Title
CN102872391A (en) Chinese medicinal gel for treating gynecological inflammation and preparation method thereof
CN112569332A (en) Application of bupleurum tenue extract in treating viral pneumonia
CN103417703A (en) Medicine for treating dysentery of pigs
CN109966434B (en) Traditional Chinese medicine composition, traditional Chinese medicine compound preparation, and preparation method and application thereof
CN112675212A (en) Scutellaria baicalensis ointment and preparation method and application thereof
CN103751316B (en) A kind of there is antifungal activity waistcoat seed extract and all kinds of preparation and application
CN105168385A (en) Antibacterial and itching-relieving medicine composition and preparing method thereof
CN104547180A (en) Cream for treating chilblain and preparation method for cream
CN108186957B (en) Traditional Chinese medicine composition for treating poultry multi-cause respiratory system diseases and preparation method thereof
CN104606385A (en) Traditional Chinese medicine preparation for treating paronychia
CN114288367B (en) Traditional Chinese medicine composition for treating cough
CN114099609B (en) Pharmaceutical composition for treating cough and preparation method thereof
WO2011016652A2 (en) Composition for controlling anal fistulae and method for preparing same
CN109316551A (en) A kind of Chinese medicine composition and preparation method thereof for treating acpuei pharyngitis
CN102188483B (en) Extract for treating pharyngolaryngitis and preparation method thereof
CN104644889A (en) Finger pulp pustule treating external application paste
CN104644891A (en) Felon treating traditional Chinese medicine preparation
CN111467427B (en) Traditional Chinese medicine composition, extract thereof and application of traditional Chinese medicine composition in preventing and treating respiratory virus infection
CN111358906A (en) Traditional Chinese medicine composition suitable for exogenous diseases
CN104623112A (en) Plaster for treating snake-head furuncle
CN112675268B (en) Composition for treating dysmenorrhea and preparation method thereof
CN104547908A (en) Traditional Chinese medicine composition for treating urticaria and preparation method of traditional Chinese medicine composition
CN109498705A (en) The preparation method and analgesia purposes of Ternstroemia gymnanthera extract
CN113876860A (en) Pharmaceutical composition for treating ulcerative colitis
CN104606444A (en) Traditional Chinese anesthesia medicine for tooth extraction and preparation method of traditional Chinese anesthesia medicine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20210420

RJ01 Rejection of invention patent application after publication